This ETF is one of several options for achieving exposure to the pharma industry, a corner of the health care market that is capable of delivering big returns but that also comes with some unique risk factors. Given this investment objective, PPH is probably more useful for those looking to achieve tactical exposure to this specific corner of the market; the appeal to buy-and-holders will be limited since many of the components are included in more broad-based funds.
A couple aspects of PPH are noteworthy. First, though PPH is now structured as a true ETF, it used to be one of the HOLDRS products offered by Merrill Lynch. Some of the concentration that was characteristic of those products remains in PPH; the portfolio is relatively shallow and concentration in the top allocations is significant. Further, PPH includes only U.S. stocks, meaning that some of the biggest players in the pharmaceutical industry are excluded from the underlying portfolio.
PPH is a decent option for pharma exposure, but there are probably some better ETFs out there for tapping into this segment of the market. IHE offers better depth of holdings, while DRGS may be appealing to those looking to achieve truly global exposure.
| Segment | Equity: Global Pharmaceuticals |
| Category | Sector |
| Focus | Health Care |
| Niche | Pharmaceuticals |
| Strategy | Vanilla |
| Weighting Scheme | Market Cap |
This section compares how balanced and deep this ETF is relative to its peers.
| PPH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Number of Holdings | 25 | 89 | 25 |
| % of Assets in Top 10 | 58.37% | 43.17% | 58.37% |
| % of Assets in Top 15 | 81.31% | 55.66% | 81.31% |
| % of Assets in Top 50 | 99.99% | 90.47% | 99.99% |
| PPH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Large (>12.9B) | 85.56% | 49.55% | 85.56% |
| Mid (>2.7B) | 13.83% | 27.02% | 13.83% |
| Small (>600M) | 0.61% | 17.62% | 0.61% |
| Micro (<600M) | 0.00% | 5.47% | 0.00% |
This section compares the P/E ratio of this ETF to its peers.
This section compares the dividend yield of this ETF to its peers.
| PPH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Dividend | $ 0.66 | $ 0.31 | $ 0.66 |
| Dividend Date | 2023-04-03 | N/A | N/A |
| Annual Dividend Rate | $ 1.42 | $ 0.48 | $ 1.42 |
| Annual Dividend Yield | 1.88% | 0.50% | 1.88% |
View charts featuring PPH price and volume data.
View charts featuring ETF fund flow data.
5 Day Net Flows: -18.9 M 1 Month Net Flows: 4.72 M 3 Month Net Flows: -9.37 M 6 Month Net Flows: -192.2 M 1 Year Net Flows: -66.97 M 3 Year Net Flows: 120.85 M 5 Year Net Flows: 70.14 M 10 Year Net Flows: 7.31 MView charts that break down the influence that fund flows and price had on overall assets.
5 Day Net AUM Change: -25.88 MThe adjacent table gives investors an individual Realtime Rating for PPH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETF Database Pro. To view information on how the ETF Database Realtime Ratings work, click here.
This section compares the cost efficiency of this ETF to its peers.
| Max ST Capital Gains Rate | 39.60% |
| Max LT Capital Gains Rate | 20.00% |
| Tax On Distributions | Qualified dividends |
| Distributes K1 | No |
This section shows how this ETF has performed relative to its peers. Returns over 1 year are annualized.
| PPH |
ETF Database
Category Average |
Factset Segment
Average |
|
|---|---|---|---|
| 1 Month Return | -4.02% | -1.37% | -4.02% |
| 3 Month Return | 0.93% | -0.09% | 0.93% |
| YTD Return | -1.79% | -0.83% | -1.79% |
| 1 Year Return | -1.72% | 3.25% | -1.72% |
| 3 Year Return | 8.07% | 0.18% | 8.07% |
| 5 Year Return | 7.38% | 2.69% | 7.38% |
The following charts reflect the geographic spread of PPH's underlying holdings.
| Region | Percentage |
|---|---|
| North, Central and South America | 99.99% |
| Country | Percentage |
|---|---|
| United States | 57.05% |
| United Kingdom | 14.69% |
| Denmark | 6.39% |
| Switzerland | 5.72% |
| France | 4.77% |
| Japan | 4.46% |
| Ireland | 3.47% |
| Israel | 2.63% |
| Canada | 0.81% |
The following charts reflect the allocation of PPH's underlying holdings.
| Sector | Percentage |
|---|---|
| Health Technology | 84.65% |
| Distribution Services | 15.34% |
| Market Cap | Percentage |
|---|---|
| Large | 85.56% |
| Mid | 13.83% |
| Small | 0.61% |
| Micro | 0.0% |
| Region | Percentage |
|---|
| Asset | Percentage |
|---|---|
| Share/Common/Ordinary | 61.33% |
| American Depositary Receipt | 38.66% |
| Sector | Percentage |
|---|---|
| Health Technology | 84.65% |
| Distribution Services | 15.34% |
This section shows how the volatility of this ETF compares to the peer group ETF Database Category.
| 5 Day Volatility | 60.40% |
| 20 Day Volatility | 9.76% |
| 50 Day Volatility | 11.66% |
| 200 Day Volatility | 11.54% |
| Beta | 0.72 |
| Standard Deviation | 3.51% |
ETF Database's Financial Advisor Reports are designed as an easy handout for clients to explain the key information on a fund. Includes new analyst insights and classification data.
Fact sheets are issued by the ETF provider and framed by ETF Database. Information contained within the fact sheet is not guaranteed to be timely or accurate.
Investors looking for equities suddenly have more than a few options to consider in this...
Here is a look at the 25 best and 25 worst ETFs from the past trading week. Traders can use this...
This week was even slower than last week, and it was all because of Memorial Day. The most...
ETF Trends and ETF Database , the preeminent digital platforms for ETF news, research, tools, video, webcasts, native content channels, and more. The ETF Trends and ETF Database brands have been trusted amongst advisors, institutional investors, and individual investors for a combined 25 years. The firms are uniquely positioned to aid advisor’s education, adoption, and usage of ETFs, as well as the asset management community’s transition from traditionally analog to digital interactions with the advisor community.
Our team at ETF Database is committed to making our website the premier source of information on ETF investing with the world’s highest quality ETF tools, content, and resources.
ETF Database analysts have a combined 50 years in the ETF and Financial markets, covering every asset class and investment style. The team monitors new filings, new launches and new issuers to make sure we place each new ETF in the appropriate context so Financial Advisors can construct high quality portfolios.
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...